Japan’s economic growth likely cooled sharply in Q3 in test for BOJ policy: Reuters poll
Japan must avoid issuing debt to fund fresh spending, IMF says
This year, 2024, looks set to be the most profitable yet for hackers, with four ransom demands paid in the tens of millions of dollars. © 2024 TechCrunch. All rights reserved. For personal use only…
Companies are concerned that their eagerness to adopt AI has made them more vulnerable to cyberthreats. Per a recent poll of over 350 IT leaders, more than half of the executives surveyed said the complexity of AI applications weakened their organization’s cybersecurity posture. More than two-fifths of executives believe their security teams lack the skills…
Autonomous vehicle technology startup Aurora Innovation is targeting April 2025 for commercial deployment of its autonomous trucks, pushing its timeline back by about a quarter. The company had originally planned to launch by the end of 2024. The company said it delayed the launch so it can continue to validate its self-driving technology. …
Former NFL quarterback and civil rights activist Colin Kaepernick took the stage at TechCrunch Disrupt 2024 on Wednesday to talk about the challenges that people who want to disrupt something are facing — both inside and outside of the tech world. “One of the biggest challenges that you will likely face when you try to…
Credit card fraud is a growing problem, but with a few simple steps, you can significantly reduce your risk…
Welcome to the third and final day of TechCrunch Disrupt 2024 at Moscone West in San Francisco! The excitement here is still in full swing, and there’s no slowing down. If you thought it was too late to join, think again—there’s still time to register and be part of the action…
Korea Zinc shares plunge for second day ahead of watchdog briefing
Archon Biosciences, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding. The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development…





